Related Experiment Video
Updated: May 16, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Ruling out cardiac failure: cost-benefit analysis of a sequential testing strategy with NT-proBNP before
Maria-José Ferrandis1, Ingvar Ryden, Tomas L Lindahl
1Department of Clinical Chemistry, Blekinge County Hospital, Karlskrona, Sweden. mjferrandis@gmail.com
Insights
Implementing NT-proBNP screening can significantly cut echocardiography use and costs for suspected cardiac failure. This strategy offers substantial economic benefits for healthcare systems.
Area of Science:
- Cardiology
- Health Economics
- Biomarker Research
Background:
- Echocardiography is a key diagnostic tool for cardiac failure but is resource-intensive.
- Biomarkers like NT-proBNP may help optimize diagnostic pathways.
- Reducing unnecessary echocardiographies can improve efficiency and lower healthcare costs.
Purpose of the Study:
- To evaluate the economic advantages of using NT-proBNP testing sequentially.
- To determine the potential reduction in echocardiography demand through this strategy.
Main Methods:
- Retrospective analysis from a third-party payer perspective.
- Data collected from three Swedish counties (Blekinge, Östergötland, Uppland).
- Cost-effectiveness assessed using NT-proBNP cut-off levels of 400 pg/mL and 300 pg/mL.
Main Results:
- A 33%-36% cost reduction was observed with the 400 pg/mL cut-off.
- A 28%-29% cost reduction was observed with the 300 pg/mL cut-off.
- This translates to an estimated annual saving of €2-5 million per million inhabitants.
Conclusions:
- NT-proBNP serves as an effective screening tool to reduce echocardiography procedures.
- This strategy significantly lowers healthcare costs associated with diagnosing cardiac failure.
- Sequential NT-proBNP testing offers a cost-effective approach in cardiac diagnostics.
Objectives:
To estimate the possible economic benefit of a sequential testing strategy with NT-proBNP to reduce the number of echocardiographies.
Methods:
Retrospective study in a third-party payer perspective. The costs were calculated from three Swedish counties: Blekinge, Östergötland, and Uppland. Two cut-off levels of NT-proBNP were used: 400 and 300 pg/mL. The cost-effectiveness of the testing strategy was estimated through the short-term cost avoidance and reduction in demand for echocardiographies.
Results:
The estimated costs for NT-proBNP tests and echocardiographies per county were reduced by 33%-36% with the 400 pg/mL cut-off and by 28%-29% with the 300 pg/mL cut-off. This corresponded to a yearly cost reduction of approximately €2-5 million per million inhabitants in these counties.
Conclusion:
The use of NT-proBNP as a screening test could substantially reduce the number of echocardiographies in the diagnostic work-up of patients with suspected cardiac failure, as well as the associated costs.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization I: Pre-Procedure Overview
Dysrhythmias V: Evaluating Dysrhythmias
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...